Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab
2020
ABSTRACTBackground. Immune-checkpoint inhibitors have radically changed the treatment landscape of Non-Small-Cell Lung Cancer (NSCLC). It is still unclear whether specific clinical characteristics ...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
24
References
8
Citations
NaN
KQI